Home › Research › Biomarkers
Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank
Xin Huang, Xiaolei Han, Hongli Chang, Tianyu Yu, Yi Dong, Ming Mao, Jiahao Ding, Xuewei Li et al.. Molecular psychiatry, 2025-08-28
Topic: Plasma and spinal-fluid biomarkers
Plain-language summary
Plasma amyloid-β(Aβ)42/40 ratio, glial fibrillary acidic protein (GFAP), neurofilament light (NfL), and phosphorylated tau181(p-tau181) are promising biomarkers for Alzheimer's disease (AD)-related pathology. We aimed to explore the longitudinal trajectories of these biomarkers in association with changes in structural brain markers and cognition, and the impact of cognitive reserve on their associations with cognitive function. This cohort study included 1270 individuals (mean age 59.7 years; 58.9% women) derived from the UK Biobank who had data on plasma biomarkers available at baseline (2014-2020); of these, data were available in 904 individuals for brain MRI scans and in 1183 for cognitive function. In 2021-2022, follow-up brain MRI markers and cognitive function were assessed. Plasma Aβ, GFAP, NfL, and p-tau181 were quantified using single-molecule array technology. Brain MRI scans were used to assess atrophic brain measures and white matter microstructures. Cognitive reserve was indexed by education, with college degree or above being defined as high cognitive reserve. Higher baseline plasma GFAP and NfL were significantly associated with brain atrophy and impaired white matter microstructure. The longitudinal increase in plasma GFAP was correlated with accelerated deterioration in processing speed (β = -0.041, P = 0.002) and visual attention (β = -0.048, P = 0.001), and with impaired white matter microstructure. Importantly, high cognitive reserve significantly mitigated the association between increases in plasma GFAP and NfL and accelerated decline in processing speed. These results indicate that plasma GFAP and NfL are surrogate biomarkers for structural brain health and cognitive health, and that high cognitive reserve may modify the cognitive trajectories associated with Alzheimer's pathology.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Huang, X., Han, X., Chang, H., Yu, T., Dong, Y., Mao, M., et al. (2026). Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank. Molecular psychiatry. https://doi.org/10.1038/s41380-025-03166-y
Vancouver
Huang X, Han X, Chang H, Yu T, Dong Y, Mao M, et al. Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank. Molecular psychiatry. 2026. doi:10.1038/s41380-025-03166-y. PMID: 40877465.
BibTeX
@article{huang2026-40877465,
author = {Huang, Xin and Han, Xiaolei and Chang, Hongli and Yu, Tianyu and Dong, Yi and Mao, Ming and Ding, Jiahao and Li, Xuewei and others},
title = {{Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank}},
journal = {Molecular psychiatry},
year = {2026},
doi = {10.1038/s41380-025-03166-y},
pmid = {40877465},
url = {https://doi.org/10.1038/s41380-025-03166-y}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Higher baseline plasma GFAP and NfL were significantly associated with brain atrophy and impaired white matter microstructure.
- Importantly, high cognitive reserve significantly mitigated the association between increases in plasma GFAP and NfL and accelerated decline in processing speed.
- These results indicate that plasma GFAP and NfL are surrogate biomarkers for structural brain health and cognitive health, and that high cognitive reserve may modify the cognitive trajectories associated with Alzheimer's pathology.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcohort study
- Participants1,270
- Effect size58.9%
- Evidence strengthModerate
How this study scored 79/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 44 of the 56 points we could judge it on, which is 79 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Molecular psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,270 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40877465) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 44 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 44 of the 56 points we could judge it on is 79 out of 100. |
| Total | 79 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “p-tau217”
692 studies in the library carry the topic tag “p-tau217”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 692 tagged studies.